Additionally, in a recent study by Al-Salam et al. (2021), cisplatin treatment in Gal3 knock-out mice was associated with a greater burden of ATN, as well as increased levels of plasma urea, creatinine, cathepsin B, and cathepsin D compared to WT mice. The gene discussed is LGALS3; the disease is oculocutaneous albinism type 1.